Congenital facial weakness (CFW) disorders are a heterogeneous group of rare conditions, that present at birth, with reduced facial movement, and mask-like facies. This study utilized a multimodality approach to examine the craniofacial and intraoral phenotypes among CFW disorders: Moebius syndrome (MBS), Hereditary Congenital Facial Palsy (HCFP), β-tubulin isotype 3 syndrome (CFEOM3A-TUBB3), Carey-Fineman-Ziter syndrome (CFZS), and a group of rarer disorders (Other).
Design
Prospective cohort study.
Setting: Dental clinic.
Participants: Sixty individuals (sex ratio 1:1, mean age 26.2 ± 17.5 years) with a diagnosis of CFW.
Interventions: Deep clinical craniofacial and dental phenotyping, three-dimensional facial surface and cone-beam computed tomography scans, and cephalometric and geometric morphometric analyses.
Results
CFEOM3A-TUBB3, MBS, and CFZS groups had the highest prevalence of craniofacial anomalies; HCFP individuals were least affected. CFEOM3A-TUBB3 had a higher prevalence of short lower face (75%), poor oral hygiene (100%)/decay (75%), and Class II malocclusion (87.5%). Moebius syndrome was associated with lagophthalmos (90.9%), tongue fissures (72.4%), tight/small oral orifice (51.7%), and tongue fasciculations (50%). Carey-Fineman-Ziter syndrome had oblong facial shape (100%), downward lip commissures (100%), and abnormal hearing (60%). Moderate-severe decay/gingivitis correlated with restricted oral orifice, common among patients with facial animation/sling surgery. Morphologically, the CFW cohort had a relatively small craniofacial centroid size, anthropometric measurements, and distinct craniofacial shapes for each subtype.
Conclusions
Congenital facial weakness can result in abnormal craniofacial development in addition to the loss of facial movement. Multimodality phenotypic characterization of CFW disorders elucidated key clinical findings and distinct craniofacial shape segregation among the different groups.
WebbBDManoliIEngleECJabsEW. A framework for the evaluation of patients with congenital facial weakness. Orphanet J Rare Dis. 2021;16(1):158.
2.
WhitmanMCEngleEC. Ocular congenital cranial dysinnervation disorders (CCDDs): insights into axon growth and guidance. Hum Mol Genet. 2017;26(R1):R37-R44.
3.
Di GioiaSAConnorsSMatsunamiN, Cannavino J, Rose MF, Gilette NM, Artoni P, de Macena Sobreira NL, Chan WM, et al.A defect in myoblast fusion underlies Carey-Fineman-Ziter syndrome. Nat Commun. 2017 Jul 6;8:16077.
4.
VerzijlHTvan der ZwaagBLammensMten DonkelaarHJPadbergGW. The neuropathology of hereditary congenital facial palsy vs Mobius syndrome. Neurology. 2005;64(4):649-653.
5.
MacKinnonSOystreckDTAndrewsCChanWMHunterDGEngleEC. Diagnostic distinctions and genetic analysis of patients diagnosed with Moebius syndrome. Ophthalmology. 2014;121(7):1461-1468.
6.
RuckerJCWebbBDFrempongTGasparHNaidichTPJabsEW. Characterization of ocular motor deficits in congenital facial weakness: Moebius and related syndromes. Brain. 2014;137(Pt 4):1068-1079.
7.
VerzijlHTvan der ZwaagBCruysbergJRPadbergGW. Mobius syndrome redefined: a syndrome of rhombencephalic maldevelopment. Neurology. 2003;61(3):327-333.
8.
MillerG. Neurological disorders. The mystery of the missing smile. Science. 2007;316(5826):826-827.
9.
CartaAMoraPNeriAFavillaSSadunAA. Ophthalmologic and systemic features in mobius syndrome an Italian case series. Ophthalmology. 2011;118(8):1518-1523.
10.
VenturaBVMillerMTDandaDCartaABrandtCTVenturaLO. Profile of ocular and systemic characteristics in mobius sequence patients from Brazil and Italy. Arq Bras Oftalmol. 2012;75(3):202-206.
11.
MillerMTVenturaLStromlandK. Thalidomide and misoprostol: ophthalmologic manifestations and associations both expected and unexpected. Birth Defects Res A Clin Mol Teratol. 2009;85(8):667-676.
12.
Ruge-PenaNOValenciaCCabreraDAguirreDCLoperaF. Moebius syndrome: craniofacial clinical manifestations and their association with prenatal exposure to misoprostol. Laryngoscope Investig Otolaryngol. 2020;5(4):727-733.
13.
PatelRMLiuDGonzaga-JaureguiC, et al.An exome sequencing study of Moebius syndrome including atypical cases reveals an individual with CFEOM3A and a TUBB3 mutation. Cold Spring Harb Mol Case Stud. 2017;3(2):a000984.
14.
Tomas-RocaLTsaalbi-ShtylikAJansenJG, et al.De novo mutations in PLXND1 and REV3L cause mobius syndrome. Nature Communications. 2015;6:7199.
15.
TenneyAPDi GioiaSAWebbBD, Chan WM, de Boer E, Garnai SJ, Barry BJ, Ray T, Kosicki M, Robson CD, et al.Noncoding variants alter GATA2 expression in rhombomere 4 motor neurons and cause dominant hereditary congenital facial paresis. Nat Genet. 2023;55(7):1149-1163.
16.
UygunerZOToksoyGAltunogluUOzgurHBasaranSKayseriliH. A new hereditary congenital facial palsy case supports arg5 in HOX-DNA binding domain as possible hot spot for mutations. Eur J Med Genet. 2015;58(6–7):358-363.
17.
VogelMVelleuerESchmidt-JimenezLF, Mayatepek E, Borkhardt A, Alawi M, Kutsche K, Kortüm F.Homozygous HOXB1 loss-of-function mutation in a large family with hereditary congenital facial paresis. Am J Med Genet A. 2016;170(7):1813-1819.
18.
SahinYGungorOAyazA, Güngör G, Sahin B, Yaykasli K, Ceylaner S.A novel homozygous HOXB1 mutation in a turkish family with hereditary congenital facial paresis. Brain Dev. 2017;39(2):166-170.
19.
WebbBDShaabanSGasparH, Cunha LF, Schubert CR, Hao K, Robson CD, Chan WM, Andrews C, MacKinnon S, et al.HOXB1 founder mutation in humans recapitulates the phenotype of Hoxb1-/- mice. Am J Hum Genet. 2012;91(1):171-179.
20.
DohertyEJMacyMEWangSMDykemanCPMelansonMTEngleEC. CFEOM3: a new extraocular congenital fibrosis syndrome that maps to 16q24.2-q24.3. Invest Ophthalmol Vis Sci. 1999;40(8):1687-1694.
21.
MackeyDAChanWMChanC, Gillies WE, Brooks AM, O'Day J, Engle EC.Congenital fibrosis of the vertically acting extraocular muscles maps to the FEOM3 locus. Hum Genet. 2002;110(5):510-512.
22.
CareyJCFinemanRMZiterFA. The robin sequence as a consequence of malformation, dysplasia, and neuromuscular syndromes. J Pediatr. 1982;101(5):858-864.
23.
TischfieldMABarisHNWuC, Rudolph G, Van Maldergem L, He W, Chan WM, Andrews C, Demer JL, Robertson RL, et al.Human TUBB3 mutations perturb microtubule dynamics, kinesin interactions, and axon guidance. Cell. 2010;140(1):74-87.
24.
ChewSBalasubramanianRChanWM, Kang PB, Andrews C, Webb BD, MacKinnon SE, Oystreck DT, Rankin J, Crawford TO, et al.A novel syndrome caused by the E410 K amino acid substitution in the neuronal beta-tubulin isotype 3. Brain. 2013;136(Pt 2):522-535.
25.
WhitmanMCBarryBJRobsonCD, Facio FM, Van Ryzin C, Chan WM, Lehky TJ, Thurm A, Zalewski C, King KA, et al.TUBB3 Arg262his causes a recognizable syndrome including CFEOM3, facial palsy, joint contractures, and early-onset peripheral neuropathy. Hum Genet. 2021;140(12):1709-1731.
26.
Hedberg-OldforsCLindbergCOldforsA. Carey-Fineman-Ziter syndrome with mutations in the myomaker gene and muscle fiber hypertrophy. Neurol Genet. 2018;4(4):e254.
27.
RyanAMarshallTFitzPatrickDR. Carey-Fineman-Ziter (CFZ) syndrome: report on affected sibs. Am J Med Genet. 1999;82(2):110-113.
28.
AlrohaifHTopfAEvangelistaTLekMMcArthurDLochmullerH. Whole-exome sequencing identifies mutations in MYMK in a mild form of Carey-Fineman-Ziter syndrome. Neurol Genet. 2018;4(2):e226.
29.
BaraitserMReardonW. New case of the Carey-Fineman-Ziter syndrome. Am J Med Genet. 1994;53(2):163-164.
30.
DufkeARiethmullerJEndersH. Severe congenital myopathy with Mobius, Robin, and Poland sequences: New aspects of the Carey-Fineman-Ziter syndrome. Am J Med Genet A. 2004;127A(3):291-293.
31.
VerloesABitounPHeuskinA, et al.Mobius sequence, Robin complex, and hypotonia: severe expression of brainstem disruption spectrum versus Carey-Fineman-Ziter syndrome. Am J Med Genet A. 2004;127A(3):277-287.
32.
MillayDPO'RourkeJRSutherlandLB, Bezprozvannaya S, Shelton JM, Bassel-Duby R, Olson EN.Myomaker is a membrane activator of myoblast fusion and muscle formation. Nature. 2013;499(7458):301-305.
33.
ShiJCaiMSiYZhangJDuS. Knockout of myomaker results in defective myoblast fusion, reduced muscle growth and increased adipocyte infiltration in zebrafish skeletal muscle. Hum Mol Genet. 2018;27(20):3542-3554.
34.
JapeeSJordanJLichtJ, Lokey S; Moebius Syndrome Research Consortium; Chen G, Snow J, Jabs EW, Webb BD, Engle EC, et al.Inability to move one's face dampens facial expression perception. Cortex. 2023;169:35-49.
35.
LehkyTJosephRToroC, Wu T, Van Ryzin C, Gropman A, Facio FM, Webb BD, Jabs EW, Barry BS, et al.Differentiating Moebius syndrome and other congenital facial weakness disorders with electrodiagnostic studies. Muscle Nerve. 2021;63(4):516-524.
36.
LibertonDKAlmpaniKMishraR, Bassim C, Van Ryzin C, On Behalf Of The Moebius Syndrome Research Consortium, Webb BD, Jabs EW, Engle EC, Collins FS, et al.Oral health-related quality of life in rare disorders of congenital facial weakness. Int J Environ Res Public Health. 2024;21(5):615.
37.
SadeghiNHutchinsonEVan RyzinC, Fitz Gibbon EJ, Butman JA, Webb BD, Facio F, Brooks BP, Collins FS, Jabs EW, et al.Brain phenotyping in Moebius syndrome and other congenital facial weakness disorders by diffusion MRI morphometry. Brain Commun. 2020;2(1):fcaa014.
38.
LeeASAyersLJKosickiM, Chan WM, Fozo LN, Pratt BM, Collins TE, Zhao B, Rose MF, Sanchis-Juan A, et al.A cell type-aware framework for nominating non-coding variants in Mendelian regulatory disorders. Nat Commun. 2024;15(1):8268.
39.
JurgensJABarryBJChanWM, MacKinnon S, Whitman MC, Matos Ruiz PM, Pratt BM, England EM, Pais L, Lemire G, et al.Expanding the genetics and phenotypes of ocular congenital cranial dysinnervation disorders. Genet Med. 2025;27(4):101216.
40.
LibertonDKMishraRBeachM, Raznahan A, Gahl WA, Manoli I, Lee JS.Comparison of three-dimensional surface imaging systems using landmark analysis. J Craniofac Surg. 2019;30(6):1869-1872.
41.
LibertonDKVermaPContrattoALeeJS. Development and validation of novel three-dimensional craniofacial landmarks on cone-beam computed tomography scans. J Craniofac Surg. 2019;30(7):e611-e615.
42.
Cignoni PCMCorsiniMDellepianeMGanovelliFRanzugliaG. Meshlab: An open-source mesh processing tool. Computing.2008;1:129-136.
43.
WeinbergSMRZacharyDKHeikeMJCunninghamMJHechtCLKauMLHowJTMurrayJCWehbyGLMorenoLM,et al.The 3D facial norms database: Part 1. A web-based craniofacial anthropometric and image repository for the clinical and research community. Cleft Palate Craniofac J. 2015;53(6):e185-e197.
44.
AlmpaniKLibertonDKJaniP, Keyvanfar C, Mishra R, Curry N, Orzechowski P, Frischmeyer-Guerrerio PA, Lee JS.Loeys-Dietz and Shprintzen-Goldberg syndromes: analysis of TGF-beta-opathies with craniofacial manifestations using an innovative multimodality method. J Med Genet. 2022 Oct;59(10):938-946
45.
WebsterMSheetsHD. A practical introduction to landmark-based geometric morphometrics. The Paleontological Society Papers. 2010;16:163-188.
46.
Landi FOHP. Applying geometric morphometrics to digital reconstruction and anatomical investigation. Adv Exp Med Biol. 2019;1171:55-71.
47.
MitteroeckerPGunzP. Advances in geometric morphometrics. Evol Biol.2009/06/01 2009;36(2):235-247.
48.
JolliffeIT. Principal component analysis. (2nd ed.). New York. Springer-Verlag; 2002.
49.
KlingenbergCP. Morphoj: An integrated software package for geometric morphometrics. Mol Ecol Resour. 2011;11(2):353-357.
50.
HontanillaBVicente-RuizM. Tips and pearls for recovering symmetry after facial palsy using a tendon sling: our 20-year experience. Facial Plast Surg Aesthet Med. 2021;23(6):449-454.
51.
Martins MussiMCMoffaECastroT, Lira Ortega A, Freitas G, Braga M, Siqueira WL, Cury Gallottini MH.Salivary parameters and oral health in the Moebius syndrome. Spec Care Dentist. 2016;36(5):265-270.
52.
De Serpa PintoMVDe MagalhaesMHNunesFD. Moebius syndrome with oral involvement. Int J Paediatr Dent. 2002;12(6):446-449.
53.
CastroTOrtegaAOMussiMCBragaMMGallottiniM. Caries experience in individuals with Moebius syndrome. Pediatr Dent. 2016;38(1):68-71.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
